Windlas Biotech

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0H5O01029
  • NSEID: WINDLAS
  • BSEID: 543329
INR
776.00
-14.95 (-1.89%)
BSENSE

Dec 05

BSE+NSE Vol: 8.73 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Net Sales
432.49
362.15
297.46
252.67
226.21
203.60
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
432.49
362.15
297.46
252.67
226.21
203.60
Raw Material Cost
269.74
243.77
180.06
174.84
148.39
123.25
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-3.06
-17.94
7.32
-13.99
-2.01
6.99
Employee Cost
68.68
58.82
41.88
34.35
31.16
27.18
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
42.04
33.58
32.37
27.63
23.13
19.98
Total Expenditure (Excl Depreciation)
377.40
318.23
261.63
222.83
200.67
177.40
Operating Profit (PBDIT) excl Other Income
55.09
43.92
35.83
29.84
25.54
26.20
Other Income
8.88
8.97
5.86
5.47
1.91
1.31
Operating Profit (PBDIT)
63.97
52.89
41.69
35.31
27.45
27.51
Interest
2.07
1.60
0.52
0.47
0.92
0.56
Exceptional Items
0.00
0.00
0.00
0.00
0.00
-21.62
Gross Profit (PBDT)
61.90
51.29
41.17
34.84
26.53
5.33
Depreciation
15.05
12.71
6.52
5.66
6.10
6.27
Profit Before Tax
46.85
38.60
34.65
29.18
20.43
-0.93
Tax
11.38
9.46
8.56
7.19
5.44
1.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
35.46
29.14
26.10
21.99
14.99
-2.44
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
35.46
29.14
26.10
21.99
14.99
-2.44
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
-0.17
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.26
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
35.46
29.14
26.10
21.99
14.99
-2.34
Equity Capital
10.45
10.45
10.40
10.90
10.90
91.00
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
0.00
0.00
0.00
0.00
360.06
0.00
Earnings per share (EPS)
16.97
13.94
12.55
10.09
6.88
-0.09
Diluted Earnings per share
16.72
13.85
12.54
10.09
7.79
-1.29
Operating Profit Margin (Excl OI)
12.74%
12.13%
12.05%
11.81%
11.29%
12.87%
Gross Profit Margin
14.31%
14.16%
13.84%
13.79%
11.73%
2.62%
PAT Margin
8.2%
8.05%
8.77%
8.7%
6.63%
-1.28%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 19.42% vs 21.75% in Sep 2024

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2025 is 21.69% vs 11.65% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 25.43% vs 22.58% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is 29.37% vs 207.69% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Windlas Biotech With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
432.49
0
432.49
Other Operating Income
0.00
0.00
0.00
Total Operating income
432.49
0
432.49
Raw Material Cost
269.74
0
269.74
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-3.06
0
-3.06
Employee Cost
68.68
0
68.68
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
42.04
0.00
42.04
Total Expenditure (Excl Depreciation)
377.40
0
377.40
Operating Profit (PBDIT) excl Other Income
55.09
0.00
55.09
Other Income
8.88
0
8.88
Operating Profit (PBDIT)
63.97
0
63.97
Interest
2.07
0
2.07
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
61.90
0
61.90
Depreciation
15.05
0
15.05
Profit Before Tax
46.85
0
46.85
Tax
11.38
0
11.38
Provisions and contingencies
0.00
0
0.00
Profit After Tax
35.46
0
35.46
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
35.46
0
35.46
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
35.46
0
35.46
Equity Capital
10.45
0
10.45
Face Value
5.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
16.97
0
16.97
Diluted Earnings per share
16.72
0
16.72
Operating Profit Margin (Excl OI)
12.74%
0%
0.00
12.74%
Gross Profit Margin
14.31%
0%
0.00
14.31%
PAT Margin
8.20%
0%
0.00
8.20%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 432.49 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 19.42% vs 21.75% in Sep 2024

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 35.46 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 21.69% vs 11.65% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 55.09 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 25.43% vs 22.58% in Sep 2024

Half Yearly - Interest
Interest 2.07 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 29.37% vs 207.69% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.74%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024